Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Efficacy and Safety of Pasireotide Long Acting Release (LAR) Versus Octreotide LAR or Lanreotide Autogel (ATG) in Patients With Inadequately Controlled Acromegaly

Novartis Pharmaceuticals · 2010
ClinicalTrials.gov · Datasets · License: Public Domain · 2010
Open Source ↗
acromegaly, hormone disorder, growth hormone, insulin like growth factor-1, pituitary tumor, pasireotide, som230, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 872589
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.